Pheiron GmbH
- Biotech or pharma, therapeutic R&D
- IT, information
Pheiron integrates population-scale biobanks, germline genetics, and AI phenotyping to compress preclinical timelines and boost success rates by up to 4x.
We unify multi-omic data to identify high impact targets and provide actionable evidence on safety, efficacy, and patient subgroups before trials.
By refining target identification and optimizing clinical positioning, we reduce failure rates, accelerate pipelines, and unlock personalized therapies—making drug development more efficient and effective.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}